Aaron Yang

944 total citations
5 papers, 250 citations indexed

About

Aaron Yang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Aaron Yang has authored 5 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Aaron Yang's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Aaron Yang is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Aaron Yang collaborates with scholars based in United States, China and Taiwan. Aaron Yang's co-authors include Eric T. Wong, Kenneth D. Swanson, Nidhi Gera, Megan E. Cavanaugh, Mari Kuraguchi, Luke J. Taus, Patrick H. Lizotte, Meghana Kulkarni, Troy A. Luster and Nathanael S. Gray and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Cancer Research.

In The Last Decade

Aaron Yang

5 papers receiving 243 citations

Peers

Aaron Yang

ONCOL

MB

GENET

BE

PRM

Ola Rominiyi United Kingdom

Adrian Kinzel United States

Susan Clenton United Kingdom

Narasimha Kumar Karanam United States

Inderjit Daphu Norway

Einav Zeevi United States

Jérémy Guehennec France

Tanja Eisemann Germany

Joshua D. Frenster United States

Simon Khagi United States

Ola Rominiyi United Kingdom

Aaron Yang

56 ×0.6

ONCOL

108 ×1.4

MB

136 ×1.8

GENET

79 ×1.1

BE

33 ×0.5

PRM

Citations per year, relative to Aaron Yang Aaron Yang (= 1×) peers Ola Rominiyi

Countries citing papers authored by Aaron Yang

Since Specialization

Citations

This map shows the geographic impact of Aaron Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Yang more than expected).

Fields of papers citing papers by Aaron Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Yang. The network helps show where Aaron Yang may publish in the future.

Co-authorship network of co-authors of Aaron Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Yang. A scholar is included among the top collaborators of Aaron Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Yang. Aaron Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Frisch, Andrew, Bingxian Xie, Aaron Yang, et al.. (2025). Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy. Cell Metabolism. 37(4). 870–885.e8. 11 indexed citations

2.

Yang, Aaron, et al.. (2024). Stayin' Alive: Targeting Chromatin Regulators of Clonal Hematopoiesis Promotes CD8 T-cell Stemness. Cancer Research. 85(2). 200–202. 1 indexed citations

3.

Lizotte, Patrick H., Ruey‐Long Hong, Troy A. Luster, et al.. (2018). A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing. Cancer Immunology Research. 6(12). 1511–1523. 69 indexed citations

4.

Lizotte, Patrick H., Troy A. Luster, Megan E. Cavanaugh, et al.. (2018). Abstract 4935: High-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of CTL antigen-specific tumor cell killing. Cancer Research. 78(13_Supplement). 4935–4935. 4 indexed citations

5.

Gera, Nidhi, et al.. (2015). Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit. PLoS ONE. 10(5). e0125269–e0125269. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact